Evaluating Cetuximab Regimens in Head and Neck Cancer: Insights from a Retrospective Cohort Study.

Cancers (Basel) · 2025 · PMC11764294 · PMID 39857992

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A 2021 real-world retrospective study observed a trend toward improved OS in younger patients treated with platinum-based chemotherapy plus cetuximab, although the results did not reach statistical significance [ 22 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.